Fund Holdings — Altium Capital Management LLC

Total Portfolio Value
$0
Total Bought
$0
Total Sold
$34.43M
Net Transaction
-$34.43M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
None00000—0
BETTER CHOICE CO INC(SRXH)38,9840-38,984670—-67
SUNSHINE BIOPHARMA INC(SBFM)50,4660-50,466960—-96
LOGICMARK INC5,395,3080-5,395,3081070—-107
SHARPS TECHNOLOGY INC4,044,1490-4,044,1491100—-110
KARYOPHARM THERAPEUTICS INC(KPTI)49,3330-49,3331850—-185
INTELLIGENT BIO SOLUTIONS IN149,2520-149,2522150—-215
ENVVENO MEDICAL CORPORATION(NVNO)123,2560-123,2563240—-324
PROMIS NEUROSCIENCES INC574,2480-574,2483990—-399
LARIMAR THERAPEUTICS INC(LRMR)273,2040-273,2045870—-587
ANTERIS TECHNOLOGIES GLOBAL(AVR)168,5890-168,5896140—-614
NEKTAR THERAPEUTICS(NKTR)1,051,3790-1,051,3797150—-715
REZOLUTE INC(RZLT)303,9490-303,9498810—-881
ALPHA COGNITION INC(ACOG)177,4160-177,4168980—-898
SKYE BIOSCIENCE INC(SKYE)904,8650-904,8651,4390—-1,439
ESSA PHARMA INC1,050,3690-1,050,3691,6600—-1,660
XENON PHARMACEUTICALS INC(XENE)60,2510-60,2512,0210—-2,021
PROFOUND MED CORP(PROF)360,5890-360,5892,0990—-2,099
CONTINEUM THERAPEUTICS INC(CTNM)303,8570-303,8572,1210—-2,121
AVADEL PHARMACEUTICALS PLC419,1310-419,1313,2820—-3,282
XTANT MED HLDGS INC(XTNT)7,252,9980-7,252,9983,4090—-3,409
EVOLUS INC(EOLS)296,1930-296,1933,5630—-3,563
ZEVRA THERAPEUTICS INC(ZVRA)1,287,3330-1,287,3339,6420—-9,642
Page 1 of 1
Altium Capital Management LLC — 13F Holdings — Q2 2025 | TickerTrail